IL-6, calcium, salivary amylase activity and cortisol as a salivary biomarker-combination associated with obesity: a pilot study
| Authors | H. Al Habobe, E. B. Haverkort, K. Nazmi, L. K. Van Nieukerken, V. E. A. Gerdes, F. J. Bikker, R. H. H. Pieters |
|---|---|
| Published in | Frontiers in Dental Medicine |
| Publication date | 2026 |
| Research groups | Innovaties in de Preventieve Zorg, Innovative Testing in Life Sciences & Chemistry |
| Type | Article |
Summary
Introduction: As obesity continues to escalate to pandemic levels worldwide, innovative approaches for early diagnosis, risk stratification, and disease monitoring are urgently needed. Saliva presents a promising non-invasive method for biomarker-based screening in obesity. Objective: This study aimed to utilize a multi-biomarker approach to explore associations between salivary biomarkers and obesity. This was done by measuring a pre-selected panel of obesity-related salivary biomarkers and comparing their levels between individuals with and without obesity.
Downloads en links
On this publication contributed
| Language | Engels |
|---|---|
| Published in | Frontiers in Dental Medicine |
| Key words | calcium, cortisol, IL-6, obesity, sAA, saliva |
| Digital Object Identifier | 10.3389/fdmed.2025.1725865 |
| Page range | 1-8 |